{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:49:21Z","timestamp":1762102161463},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2018,2,17]],"date-time":"2018-02-17T00:00:00Z","timestamp":1518825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/about_us\/legal\/notices"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,7,1]]},"DOI":"10.1093\/jat\/bky013","type":"journal-article","created":{"date-parts":[[2018,2,2]],"date-time":"2018-02-02T04:16:40Z","timestamp":1517545000000},"page":"384-391","source":"Crossref","is-referenced-by-count":10,"title":["Anodyne by Design; Measuring the Prevalence of Esoteric Designer Opioids in Pain Management Patients"],"prefix":"10.1093","volume":"42","author":[{"given":"Melissa M","family":"Goggin","sequence":"first","affiliation":[{"name":"Department of Research & Development, MedTox Laboratories, Laboratory Corporation of America Holdings, St. Paul, MN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie D","family":"Gozum","sequence":"additional","affiliation":[{"name":"Department of Research & Development, MedTox Laboratories, Laboratory Corporation of America Holdings, St. Paul, MN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Research & Development, MedTox Laboratories, Laboratory Corporation of America Holdings, St. Paul, MN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory C","family":"Janis","sequence":"additional","affiliation":[{"name":"Department of Research & Development, MedTox Laboratories, Laboratory Corporation of America Holdings, St. Paul, MN, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,2,17]]},"reference":[{"key":"key\n\t\t\t\t20180710105107_bky013C1","first-page":"62354","article-title":"Schedules of controlled substances: rescheduling of buprenorphine from Schedule V to Schedule III","volume":"67","author":"Department of Justice Drug Enforcement Administration","year":"2002","journal-title":"Federal Register"},{"key":"key\n\t\t\t\t20180710105107_bky013C2","first-page":"37623","article-title":"Schedules of controlled substances: placement of tramadol into Schedule IV","volume":"79","author":"Department of Justice Drug Enforcement Administration","year":"2014","journal-title":"Federal Register"},{"key":"key\n\t\t\t\t20180710105107_bky013C3","first-page":"51370","article-title":"Schedules of controlled substances: placement of butorphanol Into Schedule IV","volume":"62","author":"Department of Justice Drug Enforcement Administration","year":"1997","journal-title":"Federal Register"},{"key":"key\n\t\t\t\t20180710105107_bky013C4","first-page":"49661","article-title":"Schedules of controlled substances: rescheduling of hydrocodone combination products from Schedule III to Schedule II","volume":"79","author":"Department of Justice Drug Enforcement Administration","year":"2014","journal-title":"Federal Register"},{"key":"key\n\t\t\t\t20180710105107_bky013C5","author":"Alpert","year":"2017"},{"key":"key\n\t\t\t\t20180710105107_bky013C6","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jamapsychiatry.2014.366","article-title":"The changing face of heroin use in the United States: a retrospective analysis of the past 50 years","volume":"71","author":"Cicero","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"key\n\t\t\t\t20180710105107_bky013C7","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.drugpo.2017.05.050","article-title":"Today\u2019s fentanyl crisis: prohibition\u2019s Iron Law, revisited","volume":"46","author":"Beletsky","year":"2017","journal-title":"International Journal of Drug Policy"},{"key":"key\n\t\t\t\t20180710105107_bky013C8","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.forsciint.2014.04.037","article-title":"Prevalence of heroin markers in urine for pain management patients","volume":"243","author":"Knight","year":"2014","journal-title":"Forensic Science International"},{"key":"key\n\t\t\t\t20180710105107_bky013C9","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/ADM.0000000000000324","article-title":"Misuse of novel synthetic opioids: a deadly new trend","volume":"11","author":"Prekupec","year":"2017","journal-title":"Journal of Addiction Medicine"},{"key":"key\n\t\t\t\t20180710105107_bky013C10","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0196-0644(05)81216-8","article-title":"China White epidemic: an eastern United States emergency department experience","volume":"20","author":"Martin","year":"1991","journal-title":"Annals of Emergency Medicine"},{"key":"key\n\t\t\t\t20180710105107_bky013C11","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1520\/JFS11976J","article-title":"Designer drugs: past history and future prospects","volume":"33","author":"Henderson","year":"1988","journal-title":"Journal of Forensic Science"},{"key":"key\n\t\t\t\t20180710105107_bky013C12","author":"Drug Enforcement Agency Special Testing and Research Laboratory","year":"2017"},{"key":"key\n\t\t\t\t20180710105107_bky013C13","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jemermed.2015.10.014","article-title":"Acetylfentanyl: an emerging drug of abuse","volume":"50","author":"Rogers","year":"2016","journal-title":"Journal of Emergency Medicine"},{"key":"key\n\t\t\t\t20180710105107_bky013C14","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1021\/ja01191a532","article-title":"The resolution of ethyl 1,2-Diphenyl-3-dimethylaminobutyl sulfone","volume":"70","author":"Tullar","year":"1948","journal-title":"Journal of the American Chemical Society"},{"key":"key\n\t\t\t\t20180710105107_bky013C15","author":"Huang","year":"2016"},{"key":"key\n\t\t\t\t20180710105107_bky013C16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.drugalcdep.2016.11.033","article-title":"A review: fentanyl and non-pharmaceutical fentanyls","volume":"171","author":"Suzuki","year":"2017","journal-title":"Drug and Alcohol Dependence"},{"key":"key\n\t\t\t\t20180710105107_bky013C17","first-page":"242","article-title":"Postmortem and toxicological findings in a series of furanylfentanyl-related deaths","volume":"41","author":"Guerrieri","year":"2017","journal-title":"Journal of Analytical Toxicology"},{"key":"key\n\t\t\t\t20180710105107_bky013C18","first-page":"709","article-title":"Analysis of novel synthetic opioids U-47700, U-50488 and furanyl fentanyl by LC-MS\/MS in postmortem casework","volume":"40","author":"Mohr","year":"2016","journal-title":"Journal of Analytical Toxicology"},{"key":"key\n\t\t\t\t20180710105107_bky013C19","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/jat\/bkx052","article-title":"An LC-MS-MS method for the analysis of carfentanil, 3-methylfentanyl, 2-furanyl fentanyl, acetyl fentanyl, fentanyl and norfentanyl in Postmortem and Impaired-Driving Cases","volume":"41","author":"Sofalvi","year":"2017","journal-title":"Journal of Analytical Toxicology"},{"key":"key\n\t\t\t\t20180710105107_bky013C20","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/15563650.2016.1209763","article-title":"Two cases of intoxication with new synthetic opioid, U-47700","volume":"55","author":"Domanski","year":"2017","journal-title":"Clinical Toxicology"},{"key":"key\n\t\t\t\t20180710105107_bky013C21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/15563650.2016.1209764","article-title":"Near death from a novel synthetic opioid labeled U-47700: emergence of a new opioid class","volume":"55","author":"Schneir","year":"2017","journal-title":"Clinical Toxicology"},{"key":"key\n\t\t\t\t20180710105107_bky013C22","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/15563650.2017.1303141","article-title":"Intoxications involving acrylfentanyl and other novel designer fentanyls- results from the Swedish STRIDA project","volume":"55","author":"Helander","year":"2017","journal-title":"Clinical Toxicology"},{"key":"key\n\t\t\t\t20180710105107_bky013C23","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/jat\/bkw048","article-title":"Two fatal intoxications involving butyryl fentanyl","volume":"40","author":"Poklis","year":"2016","journal-title":"Journal of Analytical Toxicology"},{"key":"key\n\t\t\t\t20180710105107_bky013C24","author":"National Institute on Drug Abuse","year":"2016"},{"key":"key\n\t\t\t\t20180710105107_bky013C25","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.forsciint.2012.02.024","article-title":"Profiling of illicit fentanyl using UHPLC-MS\/MS","volume":"220","author":"Lurie","year":"2012","journal-title":"Forensic Science International"},{"key":"key\n\t\t\t\t20180710105107_bky013C26","doi-asserted-by":"crossref","first-page":"4303","DOI":"10.1021\/acs.analchem.5b04434","article-title":"Chemical attribution of fentanyl using multivariate statistical analysis of orthogonal mass spectral data","volume":"88","author":"Mayer","year":"2016","journal-title":"Analytical Chemistry"},{"key":"key\n\t\t\t\t20180710105107_bky013C27","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1093\/jat\/bkx022","article-title":"Identification of unique metabolites of the designer opioid furanyl fentanyl","volume":"41","author":"Goggin","year":"2017","journal-title":"Journal of Analytical Toxicology"},{"key":"key\n\t\t\t\t20180710105107_bky013C28","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.annemergmed.2014.07.017","article-title":"The potential threat of acetyl fentanyl: legal issues, contaminated heroin and acetyl fentanyl \u201cdisguised\u201d as other opioids","volume":"64","author":"Stogner","year":"2014","journal-title":"Annals of Emergency Medicine"},{"key":"key\n\t\t\t\t20180710105107_bky013C29","author":"Drug Enforcement Agency Special Testing and Research Laboratory","year":"2016"}],"container-title":["Journal of Analytical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jat\/article-pdf\/42\/6\/384\/25142735\/bky013.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T05:01:47Z","timestamp":1570683707000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jat\/article\/42\/6\/384\/4868621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,17]]},"references-count":29,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2018,2,17]]},"published-print":{"date-parts":[[2018,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jat\/bky013","relation":{},"ISSN":["0146-4760","1945-2403"],"issn-type":[{"value":"0146-4760","type":"print"},{"value":"1945-2403","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,7]]},"published":{"date-parts":[[2018,2,17]]}}}